Yamamoto T, Takano R, Egashira T, Yamanaka Y
Department of Pharmacology, Medical College of Oita, Japan.
Biochem Pharmacol. 1988 Apr 15;37(8):1433-7. doi: 10.1016/0006-2952(88)90003-2.
The effects of a single and repeated administration of methamphetamine (MP) in vivo in rats on its own metabolism in vitro were investigated. In both cases, the p-hydroxylation of MP to p-hydroxymethamphetamine by a microsomal fraction from rat liver was inhibited for a period of 16 hr after the last injection of MP. This inhibition was diminished by dialysis of the microsomal preparations. In contrast, the reduced level of cytochrome P-450 in hepatic microsomes from rats pretreated with the SKF 525-A did not revert to the control value after dialysis. When microsomes were preincubated with N-hydroxymethamphetamine, which is the metabolite of MP and a potent substrate for the formation of a metabolic intermediate (MI) complex with cytochrome P-450, the content of the MI was increased and the MP-hydroxylation activity decreased in direct proportion to the length of the preincubation. These results suggest that the inhibition of MP-hydroxylation may be due to reduction of the level of cytochrome P-450 that accompanies the formation of the MI complex. Furthermore, it appears that the complex can be dissociated by dialysis.
研究了大鼠体内单次和重复给予甲基苯丙胺(MP)对其体外自身代谢的影响。在这两种情况下,末次注射MP后16小时内,大鼠肝脏微粒体部分将MP对羟基化为对羟基甲基苯丙胺的反应均受到抑制。通过对微粒体制剂进行透析,这种抑制作用减弱。相比之下,用SKF 525 - A预处理的大鼠肝脏微粒体中细胞色素P - 450水平降低,透析后未恢复到对照值。当微粒体与N - 羟基甲基苯丙胺预孵育时(N - 羟基甲基苯丙胺是MP的代谢产物,也是与细胞色素P - 450形成代谢中间体(MI)复合物的有效底物),MI的含量增加,MP - 羟基化活性与预孵育时间长度成正比降低。这些结果表明,MP - 羟基化的抑制可能是由于伴随MI复合物形成的细胞色素P - 450水平降低所致。此外,似乎该复合物可通过透析解离。